Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients

NCT04529278 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Hemodialysis
Obese

Interventions

DRUG: Liraglutide

Sponsor

Fondation Hôpital Saint-Joseph